North
America Cold Sore Treatment (for HSV 1 Virus) Market report is the broad
market research report which studies the challenges, market structures,
opportunities, driving forces, emerging trends, and competitive landscape of Healthcare
industry. Moreover, the report revises general market conditions, estimates market
share and possible sales volume of Healthcare industry, figure out the probable
market for a new product to be launched and discover the most appropriate
method for the distribution of certain product. By taking into consideration
specific base year and historic year, calculations in the report have been
performed which interprets the market performance in the forecast years by
giving information about what the market definition, classifications, applications,
and engagements are.
The North America cold sore treatment (for HSV 1 virus)
market is expected to grow in the forecast year due to the rise in market
players and the availability of advanced services. Along with this,
manufacturers are engaged in R&D activities for launching novel products in
the market. The proliferation in modes of transmission of HSV is further
boosting market growth. However, a dearth of awareness about the onset and
symptoms of cold sore and its treatment might hamper the market growth in the
forecast period.
The North America cold sore treatment (for HSV 1 virus)
market is expected to gain market growth in the forecast period of 2023 to
2030. Data Bridge Market Research
analyzes that the market is growing with a CAGR of 5.6% in the forecast period
of 2023 to 2030 and is expected to reach USD 690.51 million by 2030 from USD
446.54 million in 2022.
Download Sample PDF
of North America Cold Sore Treatment (for HSV 1 Virus) Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-cold-sore-treatment-market
Cold sores or oral herpes are small blisters-like abrasions
that occur due to the infection caused by the Herpes Simplex Virus (HSV). Cold
sores generally occur on the face, around the lips, chin, cheeks, and nostrils.
They generally cause pain and itching before they burst. HSV is one of the most
common viruses found to affect the global population and it is endemic
throughout the world. Up to 90% of people around the world have at least one
form of HSV. It generally infects the pediatric population worldwide, but
according to WHO, people aged 30-49 are at higher risk now for catching the
virus, and the prevalence of HSV increases with age.
Opportunity
·
Increasing
Use of Cold Sore Patches
The increasing cases of cold sores have created numerous
opportunities for the market players and potentially surged the demand for
treatment options required to treat the HSV-1 infection or associated disease. Due
to this reason, various key market players are investing more in HSV research
to come up with novel treatment options.
Several technological advancements are taking place for the
treatment of cold sores, including all medical research aimed at introducing
new technologies (vaccines, therapy, drugs, and patches) for the treatment of
cold sores. Patches are consistently in demand for their effectiveness against
cold sores.
Also, the strategic initiatives taken by key market players
will provide structural integrity and future opportunities for market growth in
the forecast period of 2023-2030.
Some of the major
players operating in the North America cold sore treatment (for HSV 1 virus)
market are GSK plc., Novartis AG, Viatris Inc., Hikma Pharmaceuticals PLC,
HRA Pharma, Quantum Health, URGO, Apotex Inc., Church & Dwight Co., Inc.,
Bausch Health Companies Inc., Zydus Pharmaceuticals Inc., Haleon Group of
Companies, Amparo medical Technologies, Teva Pharmaceuticals USA, Inc., Carma
Labs Inc., and Blistex Inc. among others.
Recent Developments
In October 2022, GSK plc. and Tempus, a U.S.-based precision
medicine company, entered into a three-year collaboration agreement that
provides GSK with access to Tempus’ AI-enabled platform, including its library
of de-identified patient data. Through its leading Artificial Intelligence and
Machine Learning (AI/ML) capability, GSK will work together with Tempus to
improve clinical trial design, speed up enrolment, and identify drug targets.
This will contribute to GSK’s R&D success rate and provide patients with
more personalized treatment faster.
In July 2022, Haleon Group of Companies announced the
completion of the spin-off of the healthcare business from GSK Group to Haleon
Group. Haleon is the world's leading consumer health company, with brands
trusted by millions of consumers worldwide. Its product range includes five
main categories- oral health, pain relief, respiratory health, digestive
health, and others, as well as vitamins, minerals, and dietary supplements
(VMS). Its long-standing brands such as Advil, Sensodyne, Panadol, Voltaren,
Theraflu, Otrivin, Polident, Parodontax, and Centrum are based on sound
science, innovation, and a deep understanding of people.
North
America Cold Sore Treatment (for HSV 1 Virus) Market Scope
The North America cold sore treatment (for HSV 1 virus)
market is segmented into product type, route of administration, type, gender,
drug type, end user, and distribution channel. The growth amongst these
segments will help you analyze meager growth segments in the industries and
provide the users with a valuable market overview and market insights to make
strategic decisions to identify core market applications.
Product Type
·
Medications
·
Ointments
·
Creams
·
Medicated Lip Balms
·
Cold Sore Patches
·
Non-Medicated Products
Based on product type, the market is segmented into
medications, ointments, creams, medicated lip balms, cold sore patches, and
non-medicated products.
Route of
Administration
·
Oral
·
Topical
·
Others
Based on route of administration, the market is segmented into
oral, topical, and others.
Type
·
Prescription Drugs
·
Over The Counter (OTC) Drugs
Based on type, the market is segmented into prescription
drugs and Over The Counter (OTC) drugs.
Gender
·
Male
·
Female
Based on gender, the market is segmented into male and
female.
Drug Type
·
Branded
·
Generics
Based on drug type, the market is segmented into branded and
generics.
End User
·
Hospitals
·
Specialty Clinics
·
Homecare Setting
·
Others
Based on end user, the market is segmented into hospitals,
specialty clinics, homecare setting, and others.
Distribution Channel
·
Hospital Pharmacy
·
Retail Pharmacy
·
Online Pharmacy
·
Others
Based on distribution channel, the market is segmented into
hospital pharmacy, online pharmacy, retail pharmacy and others.
Browse a Detailed
Summary of the North America Cold Sore Treatment (for HSV 1 Virus) Market Research
Report @ https://www.databridgemarketresearch.com/reports/north-america-cold-sore-treatment-market
Let’s discuss
the specifics of the report, including what you will receive and how it can
benefit you:
·
It is crucial to identify audiences before beginning a campaign. In
addition to this vital to know which countries to penetrate, we can provide you
information.
·
It allows you to determine where to focus your efforts and which regions
competition are located. You will be looking at the global market scenario,
along with the GDP Growth of that particular region. In this way, an accurate
assessment of the global market is made possible.
·
To stay competitive, every organization must stay one step ahead. By
working with us, you will get a better understanding of your competitors.
·
You will also be presented with several competitive profiles, along with
their updated financials, latest R&D developments, and projected growth for
the next few years. We will also be informing you about recent developments to
keep you up-to-date and allow you to take appropriate action.
·
Besides analyzing the segments and growth rates, we will also help you
find out the key players in this industry and identify what previous
developments have taken place. To help you focus on the right segments, we will
provide a 360-degree snapshot of this market.
Browse More Reports
https://www.databridgemarketresearch.com/reports/global-cold-sore-treatment-market
https://www.databridgemarketresearch.com/reports/asia-pacific-cold-sore-treatment-market
https://www.databridgemarketresearch.com/reports/middle-east-and-africa-cold-sore-treatment-market
https://www.databridgemarketresearch.com/reports/europe-cold-sore-treatment-market
About Data Bridge
Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational
management consulting firm with offices in India and Canada. As an innovative
and neoteric market analysis and advisory company with unmatched durability
level and advanced approaches. We are committed to uncover the best consumer
prospects and to foster useful knowledge for your company to succeed in the
market.
Data Bridge Market Research is a result of sheer wisdom and
practice that was conceived and built-in Pune in the year 2015. The company
came into existence from the healthcare department with far fewer employees
intending to cover the whole market while providing the best class analysis.
Later, the company widened its departments, as well as expands their reach by opening
a new office in Gurugram location in the year 2018, where a team of highly
qualified personnel joins hands for the growth of the company. “Even in the
tough times of COVID-19 where the Virus slowed down everything around the
world, the dedicated Team of Data Bridge Market Research worked round the clock
to provide quality and support to our client base, which also tells about the
excellence in our sleeve.”
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com
Comments
Post a Comment